Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women Article

sustainable development goals

authors

publication date

  • November 1, 2009

webpage

published in

keywords

  • Bazedoxifene
  • Breast
  • Endometrial hyperplasia
  • Ovarian
  • Raloxifene
  • Selective estrogen receptor modulator

start page

  • 1109

end page

  • 1115

volume

  • 16

issue

  • 6